Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Debt Ratio (2018 - 2023)

Historic Debt Ratio for X4 Pharmaceuticals (XFOR) over the last 5 years, with Q2 2023 value amounting to 0.0.

  • X4 Pharmaceuticals' Debt Ratio fell 9585.25% to 0.0 in Q2 2023 from the same period last year, while for Jun 2023 it was 0.0, marking a year-over-year decrease of 9585.25%. This contributed to the annual value of 0.01 for FY2022, which is 2457.38% up from last year.
  • Per X4 Pharmaceuticals' latest filing, its Debt Ratio stood at 0.0 for Q2 2023, which was down 9585.25% from 0.0 recorded in Q1 2023.
  • X4 Pharmaceuticals' 5-year Debt Ratio high stood at 0.2 for Q2 2019, and its period low was 0.0 during Q2 2023.
  • Moreover, its 4-year median value for Debt Ratio was 0.02 (2022), whereas its average is 0.06.
  • Its Debt Ratio has fluctuated over the past 5 years, first skyrocketed by 214210.59% in 2022, then plummeted by 9585.25% in 2023.
  • X4 Pharmaceuticals' Debt Ratio (Quarter) stood at 0.2 in 2019, then tumbled by 96.56% to 0.01 in 2021, then rose by 24.57% to 0.01 in 2022, then crashed by 47.87% to 0.0 in 2023.
  • Its Debt Ratio stands at 0.0 for Q2 2023, versus 0.0 for Q1 2023 and 0.01 for Q4 2022.